These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14981875)

  • 1. Working the system II. Corporate greed no longer remains the sole domain of the corporation.
    Stix G
    Sci Am; 2004 Mar; 290(3):41. PubMed ID: 14981875
    [No Abstract]   [Full Text] [Related]  

  • 2. Procedure for gene patents.
    Blecher M
    Nature; 1993 Jan; 361(6409):199. PubMed ID: 8423844
    [No Abstract]   [Full Text] [Related]  

  • 3. New rules for gene patents.
    Grisham J
    Nat Biotechnol; 2000 Sep; 18(9):921. PubMed ID: 10973202
    [No Abstract]   [Full Text] [Related]  

  • 4. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 6. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 8. Intellectual property. NIH roils academe with advice on licensing DNA patents.
    Malakoff D
    Science; 2004 Mar; 303(5665):1757-8. PubMed ID: 15031474
    [No Abstract]   [Full Text] [Related]  

  • 9. Hatch-waxman changes debated.
    Chahine K
    Nat Biotechnol; 2000 Jul; 18(7):710-1. PubMed ID: 10888831
    [No Abstract]   [Full Text] [Related]  

  • 10. OTA panel opens inquiry into patenting of genes.
    Macilwain C
    Nature; 1993 Apr; 362(6419):386. PubMed ID: 8464461
    [No Abstract]   [Full Text] [Related]  

  • 11. Patenting Dr. Venter's genetic findings: is the National Institutes of Health creating hurdles or clearing the path for biotechnology's voyage in the twenty-first century?
    Riley PJ
    J Contemp Health Law Policy; 1994; 10():309-26. PubMed ID: 10134812
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent law and human genome research at the crossroads: the need for Congressional action.
    McKay DL
    Santa Clara Comput High Technol Law J; 1994; 10(2):465-98. PubMed ID: 16514752
    [No Abstract]   [Full Text] [Related]  

  • 13. Conditionally yours.
    Nat Genet; 1998 Sep; 20(1):1-3. PubMed ID: 9731517
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH panel urges technology transfer reforms.
    Swan N
    Nat Biotechnol; 1998 Aug; 16(8):710. PubMed ID: 9702758
    [No Abstract]   [Full Text] [Related]  

  • 15. Affymetrix in new patents row.
    Ledford H
    Nature; 2008 Jul; 454(7203):377. PubMed ID: 18650873
    [No Abstract]   [Full Text] [Related]  

  • 16. Opening up the Ivory Tower.
    Wilan KH
    Cell; 2007 Jun; 129(5):847-50. PubMed ID: 17540161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many lawyers does it take...greed and legal wrangling could stifle the medical revolution.
    New Sci; 2002 May; 174(2343):3. PubMed ID: 12731531
    [No Abstract]   [Full Text] [Related]  

  • 18. Business: stepping out.
    Dalton R
    Nature; 2008 Mar; 452(7184):146. PubMed ID: 18337794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH cDNA patent rejected; backers want to amend law.
    Anderson C
    Nature; 1992 Sep; 359(6393):263. PubMed ID: 1406922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.